ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CRL Charles River Laboratories International Inc

229.03
1.22 (0.54%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Charles River Laboratories International Inc NYSE:CRL NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  1.22 0.54% 229.03 230.86 227.39 227.39 322,127 01:00:00

Statement of Changes in Beneficial Ownership (4)

10/08/2020 8:20pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Knell Michael Gunnar
2. Issuer Name and Ticker or Trading Symbol

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. [ CRL ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
CSVP&Chief Accounting Officer
(Last)          (First)          (Middle)

251 BALLARDVALE STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

8/7/2020
(Street)

WILMINGTON, MA 01887
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 8/7/2020  M  997 A$90.43 3411 D  
Common Stock 8/7/2020  M  1709 A$109.34 5120 D  
Common Stock 8/7/2020  M  735 A$144.67 5855 D  
Common Stock 8/7/2020  S  2793 D$216.5169 (1)3062 D  
Common Stock 8/7/2020  S  663 D$216.9288 (2)2399 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy) $90.43 8/7/2020  M     997  5/1/2018 5/1/2022 Common Stock 997 $0 333 D  
Stock Options (Right to Buy) $109.34 8/7/2020  M     1709  2/23/2019 2/23/2023 Common Stock 1709 $0 1710 D  
Stock Options (Right to Buy) $144.67 8/7/2020  M     735  2/22/2020 2/22/2024 Common Stock 735 $0 2206 D  

Explanation of Responses:
(1) This transaction was executed in multiple trades at prices ranging from $215.87 to $216.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(2) This transaction was executed in multiple trades at prices ranging from $216.88 to $217.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Knell Michael Gunnar
251 BALLARDVALE STREET
WILMINGTON, MA 01887


CSVP&Chief Accounting Officer

Signatures
/s/ Michael G. Knell8/10/2020
**Signature of Reporting PersonDate

1 Year Charles River Laboratories Chart

1 Year Charles River Laboratories Chart

1 Month Charles River Laboratories Chart

1 Month Charles River Laboratories Chart

Your Recent History

Delayed Upgrade Clock